drugset / Trial / NCT02865642

Cortical Ischemic Stroke and Serotonin

NCT02865642

RandomizedParallel-groupQuadruple-blindSupportive care

Summary

In this study the investigators want to test the hypotheses that, serotonergic neuromodulation increases perilesional neuroplasticity, leading to improved behavioural outcomes through a more efficient allocation of functional resources, greater structural reorganization and less remapping via alternative circuits.

Timeline

Start
2016-08
Primary completion
2020-09
Completion
2020-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Escitalopram Small molecule 20 mg

Indications